GlobeStar Therapeutics (GSTC) is teaming up with Advanced Innovative Partners (AIP) to design and implement clinical trials of Project Amethyst,…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Changes in the gene activity within immune T-cells explain why women with multiple sclerosis (MS) improve during pregnancy, a…
Altered blood levels of certain fat molecules implicated in inflammatory responses seem to correlate with disability status and markers of…
The over-the-counter antihistamine clemastine has demonstrated an ability to repair myelin, the protective coating on nerve fibers that’s damaged…
A blood-clotting protein called fibrin can activate immune cells in the brain and contribute to inflammation and neurodegeneration in…
A detailed examination of nerve tissue isolated from multiple sclerosis (MS) patients showed changes to the myelin sheath…
A non-invasive treatment called acute intermittent hypoxia, or AIH, involving periods of oxygen deprivation, was found to ease signs and…
The rate of multiple sclerosis (MS) diagnoses have remained relatively constant for almost 20 years in the U.K., according…
Modified nanocapsules containing retinoic acid can suppress inflammation and prompt the growth of cells that produce nerve fibers’ myelin coating,…
Interleukin-3 (IL-3), an inflammatory signaling protein, seems to coordinate the recruitment of immune cells from the blood into the brain,…
A protein called Mfsd2a, which transports molecules that contain omega-3 fatty acids, is essential for regulating cells that make the fatty…
Training of the pelvic muscles, provided alongside lifestyle advice via telerehabilitation — tailored exercise instruction delivered via an online…
The benefits of Mavenclad (cladribine) were sustained for up to 15 years after its last treatment course in people…
The world’s first mega-trial is recruiting people in the U.K. with progressive forms of multiple sclerosis (MS) to investigate…
Itaconate, a metabolite produced during cellular energy production activities, was found to restore the balance of immune T cells and…
The body has two distinct lineages of immune cells that can be distinguished by the presence or absence of the…
Supplementation with phosphoenolpyruvate (PEP), a molecule produced during cellular energy generation, eased the signs and symptoms of multiple sclerosis…
Using Mayzent (siponimod) and vitamin D3 as a combination therapy was found to improve motor function and promote remyelination…
Two alternative treatments for the cognitive challenges people with multiple sclerosis (MS) can face in daily life — cognitive…
The signaling protein fractalkine was found to promote the repair of myelin — the protecting coating around nerve…
Teenagers with poor sleep quality or insufficient sleep — those who sleep less than seven hours a night — are…
Within the first 12 years after the onset of symptoms, about one-fourth of people with clinically isolated syndrome —…
Uses of virtual reality-based physiotherapy to improve balance and gait in people with multiple sclerosis (MS) are linked to…
The risk of developing multiple sclerosis (MS) doesn’t seem to be influenced by consuming alcohol, according to a large-scale…
A stem cell transplant more effectively slowed disability worsening in people with active secondary progressive multiple sclerosis (SPMS)…
Myelin, the fatty-rich material surrounding nerve fibers that’s progressively damaged in multiple sclerosis (MS), provides metabolic support to…
People with relapsing-remitting multiple sclerosis (RRMS) have elevated levels of the lipocalin 2 (Lcn-2) protein in their stool samples,…
The risk of transitioning from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive multiple sclerosis (SPMS) declined significantly after…
Kesimpta (ofatumumab) may be more effective at reducing relapse rates than other disease-modifying therapies (DMTs) in Japanese adults with…
Taking the pregnancy hormone estriol in combination with Copaxone (glatiramer acetate) significantly reduced the blood levels of neurofilament light…